Liu Zhenxiu, Feng Nannan, Wang Sujing, Liu Yang, Wang Jie, Tan Yue, Dong Ying, Sun Zhewei, Du Xihao, Xu Yaqing, Tao Feng, Zhong Victor W
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200025, China.
Department of Epidemiology and Biostatistics, School of Public Health, Shanghai Jiao Tong University School of Medicine, 415 East No. 1 Building 227 South Chongqing Rd, Shanghai, China.
Nutr J. 2025 Mar 14;24(1):42. doi: 10.1186/s12937-025-01101-z.
Chinese have distinct phenotypes of type 2 diabetes (T2D) and obesity compared with people of other ethnicities, but using low-calorie diets to achieve T2D remission has never been conducted in Chinese. This study aimed to assess if T2D remission can be achieved using low-calorie formula diet (LCFD) and low-calorie real food-based diet (LCRFD) in Chinese similarly to other populations and to identify determinants of individual variability in T2D remission.
This 6-month intervention consisted of a 3-month isocaloric intensive weight loss phase (815-835 kcal/d) and a 3-month weight maintenance phase. Enrolled participants with T2D had BMI of 24-45 kg/m and HbA1c level of 6.5-12.0% (< 6.5% if on medication). Everyone stopped anti-diabetic drugs on day 1 and was assigned to receive LCFD (n = 21) or LCRFD (n = 20).
At 6 months, 29.3% of participants had ≥ 12 kg weight loss, 39.0% lost ≥ 10% weight, and 56.1% achieved T2D remission. MRI-derived liver and pancreatic fat decreased significantly. Significant improvement was also seen in insulin sensitivity, continuous glucose monitoring-derived metrics, and various other cardiometabolic risk factors but not arginine-induced insulin secretory response. There was no difference in all outcomes between LCFD and LCRFD. Compared with responders for T2D remission, nonresponders were more likely to be women, and had more fat mass, longer diabetes duration, poorer glycemic control, and lower beta-cell function.
T2D remission rate and weight loss amount following low-calorie diet intervention in Chinese people were comparable to those reported from other populations, although individual variability existed. LCFD and LCRFD were similarly effective.
The trial was registered with ClinicalTrials.gov: NCT05472272.
与其他种族的人相比,中国人患2型糖尿病(T2D)和肥胖的表型有所不同,但在中国从未进行过使用低热量饮食实现T2D缓解的研究。本研究旨在评估在中国人群中,使用低热量配方饮食(LCFD)和低热量天然食物饮食(LCRFD)是否能像其他人群一样实现T2D缓解,并确定T2D缓解个体差异的决定因素。
这项为期6个月的干预包括一个为期3个月的等热量强化减重阶段(815 - 835千卡/天)和一个为期3个月的体重维持阶段。纳入的T2D参与者体重指数(BMI)为24 - 45千克/平方米,糖化血红蛋白(HbA1c)水平为6.5 - 12.0%(如果正在服药则<6.5%)。所有人在第1天停用抗糖尿病药物,并被分配接受LCFD(n = 21)或LCRFD(n = 20)。
在6个月时,29.3%的参与者体重减轻≥12千克,39.0%的参与者体重减轻≥10%,56.1%的参与者实现了T2D缓解。磁共振成像(MRI)测量的肝脏和胰腺脂肪显著减少。胰岛素敏感性、持续葡萄糖监测指标以及各种其他心血管代谢危险因素也有显著改善,但精氨酸诱导的胰岛素分泌反应没有改善。LCFD和LCRFD在所有结果上没有差异。与T2D缓解的反应者相比,无反应者更可能是女性,并且有更多的脂肪量、更长的糖尿病病程、更差的血糖控制和更低的β细胞功能。
中国人在低热量饮食干预后的T2D缓解率和体重减轻量与其他人群报道的相当,尽管存在个体差异。LCFD和LCRFD同样有效。
该试验已在ClinicalTrials.gov注册:NCT05472272。